KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Clinical trial NCT06752473 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06752473
Sponsor: Kousai Bio Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma (NPC)EBV

Start date: 2025-01-31
Primary completion: 2026-09-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.